Samsara BioCapital, LLC

Q1 2025 13F Holdings

  • Location
    palo alto, CA
  • Num holdings

    37

  • Value ($000)

    $560,807

  • Date Filed
    05/15/2025
  • Form type
    13F-HR
  • CIK
    0001744967
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
SRRK
SRRK

SCHOLAR ROCK HLDG CORP

COM
$180.45M
32 %

5,612,896

---

KALARIS THERAPEUTICS INC

COM
$91.93M
16 %

11,448,081

MLYS
MLYS

MINERALYS THERAPEUTICS INC

COM
$90.12M
16 %

5,674,916

NGNE
NGNE

NEUROGENE INC

COM
$20.11M
4 %

1,717,127

ALMS
ALMS

ALUMIS INC

COM
$20.06M
4 %

3,266,498

---

PALVELLA THERAPEUTICS INC NE

COM
$19.02M
3 %

679,486

---

SEPTERNA INC

COM
$18.23M
3 %

3,149,128

CRGX
CRGX

CARGO THERAPEUTICS INC

COM
$17.97M
3 %

4,415,689

LENZ
LENZ

LENZ THERAPEUTICS INC

COM
$13.53M
2 %

526,390

---

UPSTREAM BIO INC

COM
$12.65M
2 %

2,067,146

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 37